In SCD null mice, it was observed that diet-induced or leptin deficiency-induced obesity was prevented due to reduced body adiposity and improved insulin sensitivity [22,23], suggesting SCD as a potential therapeutic target for metabolic complications associated with obesity [23]. This evidence concerns the gene INS and Obesity.